CPT® Code 0629T

Percutaneous injection of allogeneic cellular and/or tissue-based product, intervertebral disc, unilateral or bilateral injection, with CT guidance, lumbar; first level

The procedure described by CPT® Code 0629T involves the percutaneous injection of allogeneic cellular and/or tissue-based products into the intervertebral disc, specifically at the lumbar region. Allogeneic cells, often referred to as universal cells, are sourced from a single donor, such as umbilical cord blood, and are stored in a master cell bank. These cells are processed to meet the specific therapeutic needs of the patient. The use of allogeneic mesenchymal cells or tissue-based products, which may include materials like bone marrow or umbilical tissue, aims to address intervertebral disc degeneration. This method is designed to provide pain relief and enhance the quality of the disc without resorting to invasive surgical techniques. The procedure is performed under local anesthesia and utilizes imaging guidance, specifically computed tomography (CT), to ensure accurate placement of the injection. The injection is administered intradiscally, utilizing a ready-to-use material that contains a predetermined number of cells for each segment being treated. For billing purposes, CPT® Code 0629T is used to report the injection at the first level on one or both sides with CT guidance, while additional levels are reported using CPT® Code 0630T. This approach is considered more convenient compared to autologous cell therapy, as it eliminates the need for harvesting cells from the patient’s own body.